In her March 2002 editorial, Dr Moncrieff
In her March 2002 editorial, Dr Moncrieff raises doubts about the efficacy of antideraises doubts about the efficacy of antidepressant drugs, and argues that side-effects pressant drugs, and argues that side-effects of the active drug may explain some of the of the active drug may explain some of the differences owing to the associated indifferences owing to the associated increased expectancy of a positive effect. creased expectancy of a positive effect. Our 24-week study (Malt Our 24-week study (Malt et al et al, 1999 (Malt et al et al, ) com-, 1999 comparing the efficacy of empathic primaryparing the efficacy of empathic primarycare counselling and support combined with care counselling and support combined with placebo, a selective serotonin reuptake inhiplacebo, a selective serotonin reuptake inhibitor (sertraline) or an bitor (sertraline) or an a a 2 2 /5-HT /5-HT 2/3 2/3 antagonist antagonist (mianserin) in 372 subjects with depressed (mianserin) in 372 subjects with depressed mood does not support her arguments. mood does not support her arguments.
In our study the general practitioners In our study the general practitioners were required to systematically explore were required to systematically explore possible side-effects. This method yields a possible side-effects. This method yields a greater prevalence of side-effects than when greater prevalence of side-effects than when only spontaneously reported side-effects are only spontaneously reported side-effects are considered. The mean numbers of baselineconsidered. The mean numbers of baselinecorrected UKU-elicited side-effects (Lingcorrected UKU-elicited side-effects (Lingjaerde jaerde et al et al, 1987) during the study were , 1987) during the study were 7.11, 6.51 and 6.45 after 8 weeks of treat-7.11, 6.51 and 6.45 after 8 weeks of treatment with sertraline, mianserin and plament with sertraline, mianserin and placebo, respectively, and 3. 16, 3.09 and cebo, respectively, and 3.16, 3 .09 and 3.02 after 24 weeks of treatment (NS). This 3.02 after 24 weeks of treatment (NS). This means that prevalence of side-effects is unmeans that prevalence of side-effects is unlikely to explain the difference in response. likely to explain the difference in response.
Another observation arguing against the Another observation arguing against the hypothesis that non-specific side-effects hypothesis that non-specific side-effects may explain differences between active drug may explain differences between active drug and placebo is the fact that we obtained difand placebo is the fact that we obtained differences in response over time among the ferences in response over time among the three treatment arms. As would be expected three treatment arms. As would be expected by the pharmacodynamic profiles of the by the pharmacodynamic profiles of the drugs, mianserin induced a faster initial redrugs, mianserin induced a faster initial response, while sertraline demonstrated an sponse, while sertraline demonstrated an advantage in the long run explained by betadvantage in the long run explained by better efficacy among subjects with high neuroter efficacy among subjects with high neuroticism. At the end of the study, the ticism. At the end of the study, the physicians were not able to identify reliably physicians were not able to identify reliably the treatment given to each of their patients. the treatment given to each of their patients.
Furthermore, differences in effect size Furthermore, differences in effect size between the treatments (see Table 1 ) between the treatments (see Table 1 ) clearly demonstrated the advantage of anticlearly demonstrated the advantage of antidepressant drugs on core symptoms of depressant drugs on core symptoms of depression. These differences are well depression. These differences are well beyond the estimated mean effect size of beyond the estimated mean effect size of 0.27 reported for active placebo. 0.27 reported for active placebo.
Instead of questioning the efficacy of Instead of questioning the efficacy of antidepressant drugs in depression, attenantidepressant drugs in depression, attention should be directed at the critical tion should be directed at the critical question regarding the characteristics of question regarding the characteristics of those patients who will benefit from receivthose patients who will benefit from receiving antidepressant drugs in addition to ing antidepressant drugs in addition to psychological intervention. psychological intervention.
Lingjaerde, O., Ahlfors, U. G., Bech, P., Lingjaerde, O., Ahlfors, U. G., Bech, P., et al et al (1987) 
The UKU side effect rating scale. A new comprehensive The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional rating scale for psychotropic drugs and a cross-sectional study of side effects on neuroleptic-treated patients. study of side effects on neuroleptic-treated patients. Acta Acta Psychiatrica Scandinavica Supplementum Psychiatrica Scandinavica Supplementum, , 334 334, 1^100. , 1^100.
Malt,U. F., Robak, O. H., Madsbru, H.-P., Malt,U. F., Robak, O. H., Madsbru, H.-P., et al et al (1999) (1999) his study of the use of antidepressants his study of the use of antidepressants establishes the utility of antidepressants establishes the utility of antidepressants in mild or moderate depression in priin mild or moderate depression in primary care and contradicts the notion mary care and contradicts the notion that unblinding may have biased results. that unblinding may have biased results. He reports that there was no difference He reports that there was no difference in rates of side-effects in any of the in rates of side-effects in any of the treatment groups. However, patients treatment groups. However, patients may be able to guess whether they are may be able to guess whether they are taking active drugs without necessarily taking active drugs without necessarily reporting side-effects. Taking an active reporting side-effects. Taking an active drug may lead to a physiological experidrug may lead to a physiological experience, which reveals the nature of the ence, which reveals the nature of the treatment but may not be construed as treatment but may not be construed as unpleasant, and therefore may not be reunpleasant, and therefore may not be reported as a side-effect. Without specifiported as a side-effect. Without specifically asking patients to guess whether cally asking patients to guess whether they are taking active drugs or placebo they are taking active drugs or placebo it is not possible to know whether or it is not possible to know whether or not this effect may be occurring. In adnot this effect may be occurring. In addition, the fact that Professor Malt redition, the fact that Professor Malt reports that the active drugs were ports that the active drugs were substantially more effective than placebo substantially more effective than placebo for insomnia suggests that the drugs had for insomnia suggests that the drugs had a sedative effect which may have been a sedative effect which may have been independent of the proposed antidepresindependent of the proposed antidepressant effect and may have suggested to sant effect and may have suggested to patients that they were taking an active patients that they were taking an active medication. medication. It is also worth pointing out that It is also worth pointing out that although this trial found statistically sigalthough this trial found statistically significant differences between active drugs nificant differences between active drugs and placebo, these differences were very and placebo, these differences were very small and of doubtful clinical relevance. small and of doubtful clinical relevance. The difference in the reduction of scores The difference in the reduction of scores on the Montgomery-Asberg Depression on the Montgomery-Å sberg Depression Rating Scale (MADRS) between the active Rating Scale (MADRS) between the active drugs and placebo consisted of a maxidrugs and placebo consisted of a maximum of 3 points. The MADRS scale has mum of 3 points. The MADRS scale has a total of 60 points and mean baseline a total of 60 points and mean baseline values in this study were 27. In subjects values in this study were 27. In subjects in whom depression was characterised as in whom depression was characterised as severe or major depression, the differences severe or major depression, the differences were smaller still, and were not were smaller still, and were not statistically significant. statistically significant.
It is arguable that treatment of mild It is arguable that treatment of mild depression in primary care with antidepression in primary care with antidepressants is the worst case of the inapdepressants is the worst case of the inappropriate medicalisation of misery and propriate medicalisation of misery and social problems. This may be harmful social problems. This may be harmful to the individuals concerned by encourato the individuals concerned by encouraging reliance on physical treatments, ging reliance on physical treatments, and to society by masking the social conand to society by masking the social conditions that are the sources of modern ditions that are the sources of modern discontent. discontent. Effects of exercise on depression Effects of exercise on depression in old age in old age
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
The study by Mather The study by Mather et al et al (2002) is a laud-(2002) is a laudable work but has some important shortable work but has some important shortcomings. The control group had received comings. The control group had received health education, and the authors have jushealth education, and the authors have justified this approach. Considering the fact tified this approach. Considering the fact that well-designed studies addressing the that well-designed studies addressing the usefulness of exercise in depression in old usefulness of exercise in depression in old age are lacking, we believe inclusion of a age are lacking, we believe inclusion of a control group that did not receive another control group that did not receive another intervention other than continuing antiintervention other than continuing antidepressants could have made Mather depressants could have made Mather et al et al's 's findings more meaningful. Another issue is findings more meaningful. Another issue is attendance rate: despite the fact that exerattendance rate: despite the fact that exercise facilitated recovery from depression cise facilitated recovery from depression and that no one dropped out, the reasons and that no one dropped out, the reasons for a low mean attendance rate in the exerfor a low mean attendance rate in the exercise group remain unclear. Also, whether cise group remain unclear. Also, whether this low attendance rate contributed to the this low attendance rate contributed to the lack of significant group differences in outlack of significant group differences in outcome measures at the 34th week (final come measures at the 34th week (final assessment) needs clarification. assessment) needs clarification.
With regard to the statistical analysis, With regard to the statistical analysis, besides the analysis of outcome at certain besides the analysis of outcome at certain points, the authors could have used the points, the authors could have used the Wilcoxon test for paired samples or Wilcoxon test for paired samples or another comparable statistical test to detect another comparable statistical test to detect differences in outcome from baseline differences in outcome from baseline scores. The authors state that both groups scores. The authors state that both groups had scores of secondary outcome measures had scores of secondary outcome measures at the 10th and 34th weeks that were at the 10th and 34th weeks that were significantly different from baseline, but significantly different from baseline, but this statement is not supported by an this statement is not supported by an appropriate statistical analysis. appropriate statistical analysis.
Given that the authors had great diffiGiven that the authors had great difficulties while recruiting the study sample, culties while recruiting the study sample, rectification of the above limits could have rectification of the above limits could have made their conclusions more robust. made their conclusions more robust. Authors'reply: We are grateful to Dr JagadWe are grateful to Dr Jagadheesan and colleagues for allowing us to reheesan and colleagues for allowing us to reiterate the methodological strength of our iterate the methodological strength of our trial design. If our control group had been trial design. If our control group had been as Dr Jagadheesan proposes (continued as Dr Jagadheesan proposes (continued antidepressant treatment only), then we antidepressant treatment only), then we would wrongly have concluded that exerwould wrongly have concluded that exercise is highly effective as an adjunct to drug cise is highly effective as an adjunct to drug treatment in old age depression. In fact treatment in old age depression. In fact when compared with the effects of a strucwhen compared with the effects of a structured social intervention, group exercise tured social intervention, group exercise offered only a modest additional benefit. offered only a modest additional benefit. Our non-exercise control crucially allowed Our non-exercise control crucially allowed us to disentangle the psychosocial effects us to disentangle the psychosocial effects of coming together as a group from the of coming together as a group from the effects of exercise itself. This novel use of effects of exercise itself. This novel use of a non-exercise control intervention which a non-exercise control intervention which matched the exercise intervention in matched the exercise intervention in duration, frequency and social contact duration, frequency and social contact represents an important methodological represents an important methodological advance which future researchers will wish advance which future researchers will wish to consider (Lawlor & Hopker, 2001) . to consider (Lawlor & Hopker, 2001) .
Perhaps Salmon may shed some light on Perhaps Salmon may shed some light on the low mean attendance rate by his the low mean attendance rate by his comment that advocacy of exercise as a comment that advocacy of exercise as a treatment for depression 'must puzzle clinitreatment for depression 'must puzzle clinicians, who in treating depressed people, cians, who in treating depressed people, often have to contend with an absence of often have to contend with an absence of motivation to tackle much less strenuous motivation to tackle much less strenuous features of life's routine' (Salmon, 1990) . features of life's routine' (Salmon, 1990) .
The Results section of our paper is The Results section of our paper is succinct, in part because of editorial consuccinct, in part because of editorial constraints on article length. A typical finding straints on article length. A typical finding (such as a group comparison of reduction (such as a group comparison of reduction in Hamilton Rating Scale for Depression in Hamilton Rating Scale for Depression score at 10 weeks) gives only a comparison score at 10 weeks) gives only a comparison of proportions and the associated of proportions and the associated P P The analysis which resulted in the stated The analysis which resulted in the stated findings for secondary outcome measures findings for secondary outcome measures was a one-sample was a one-sample t t-test on the logarithms -test on the logarithms of the ratios of outcome:baseline scores. of the ratios of outcome:baseline scores.
There is a desperate need for betterThere is a desperate need for betterquality research in the area of depression, quality research in the area of depression, and we believe that our trial design offers and we believe that our trial design offers an important methodological advance. an important methodological advance. (2002) evaluated the prophylactic efficacy of citalopram in comparison lactic efficacy of citalopram in comparison with placebo in elderly patients, and stated with placebo in elderly patients, and stated 'the highly recurrent nature of major de-'the highly recurrent nature of major depression in the young and the elderly warpression in the young and the elderly warrants long-term antidepressant treatment'. rants long-term antidepressant treatment'. In view of this, is it ethical to use a placebo In view of this, is it ethical to use a placebo arm? The answer to this question depends arm? The answer to this question depends upon whether or not there is an already upon whether or not there is an already available treatment of proven or accepted available treatment of proven or accepted value. In this context, Cochrane (1989) value. In this context, Cochrane (1989) stated that 'placebo controlled trials are stated that 'placebo controlled trials are appropriate when there is no existing appropriate when there is no existing treatment for a disorder, otherwise compartreatment for a disorder, otherwise comparison trials are indicated. No new treatments ison trials are indicated. No new treatments should be introduced into medicine unless should be introduced into medicine unless they have been shown, in randomised conthey have been shown, in randomised controlled trials, to be superior to existing trolled trials, to be superior to existing treatments, or equivalent to existing treattreatments, or equivalent to existing treatment but cheaper or safer'. Similarly, secment but cheaper or safer'. Similarly, section 12.4 of the National Health and tion 12.4 of the National Health and Medical Research Council (1999) stateMedical Research Council (1999) statement on ethical conduct in research involment on ethical conduct in research involving humans states: 'the use of a placebo ving humans states: 'the use of a placebo alone or the incorporation of a non-treatalone or the incorporation of a non-treatment control group is ethically unacceptament control group is ethically unacceptable in a controlled trial where: (a) other ble in a controlled trial where: (a) other available treatment has already been clearly available treatment has already been clearly shown to be effective; and (b) there is a risk shown to be effective; and (b) there is a risk of significant harm in the absence of treatof significant harm in the absence of treatment. If there is genuine uncertainty about ment. If there is genuine uncertainty about the net clinical benefit of a treatment, a the net clinical benefit of a treatment, a placebo controlled trial or a trial with a placebo controlled trial or a trial with a no-treatment arm may be considered'. no-treatment arm may be considered'.
Declaration of interest
The use of placebo in this clinical drug The use of placebo in this clinical drug trial raises questions of deception, of patrial raises questions of deception, of patient information and of informed consent. tient information and of informed consent. The patients in the placebo group were left The patients in the placebo group were left without any active treatment for 48 without any active treatment for 48 weeks -this raises doubt as to whether paweeks -this raises doubt as to whether patients were fully informed, before giving tients were fully informed, before giving their consent, that they might receive a platheir consent, that they might receive a placebo by random allocation. We are keen to cebo by random allocation. We are keen to know why the authors did not try to know why the authors did not try to compare the efficacy of citalopram with compare the efficacy of citalopram with existing antidepressants. existing antidepressants. Authors'reply: Drs Jainer and Soni have adDrs Jainer and Soni have addressed an important issue in clinical trials dressed an important issue in clinical trials in depression when commenting on our in depression when commenting on our article. Our study was the first specifically article. Our study was the first specifically designed and conducted to evaluate the designed and conducted to evaluate the therapeutic value of prevention of recurtherapeutic value of prevention of recurrence of a depressive episode in an elderly rence of a depressive episode in an elderly population. The study was designed using population. The study was designed using the concept of the three phases of antidethe concept of the three phases of antidepressant treatment: acute, continuation pressant treatment: acute, continuation and maintenance treatment (Montgomery and maintenance treatment (Montgomery et al et al, 1988) . The study is unique in that , 1988). The study is unique in that the majority of the population had suffered the majority of the population had suffered only one documented depressive episode only one documented depressive episode upon admission into the study. upon admission into the study.
At the time the study was initiated, At the time the study was initiated, there was sparse evidence for the value of there was sparse evidence for the value of prophylactic treatment after a first episode prophylactic treatment after a first episode of depression in elderly patients. Thus, the of depression in elderly patients. Thus, the requirement that there be no 'other availrequirement that there be no 'other available treatment [that] has already been able treatment [that] has already been clearly shown to be effective' was fulfilled. clearly shown to be effective' was fulfilled.
Prior to initiating the study, the local Prior to initiating the study, the local ethics committee approved the protocol as ethics committee approved the protocol as well as the patient information and the inwell as the patient information and the informed consent form. The patient inforformed consent form. The patient information explicitly mentioned the use of mation explicitly mentioned the use of placebo in the double-blind period. All paplacebo in the double-blind period. All patients gave written informed consent before tients gave written informed consent before being included in the study. being included in the study.
Existing guidelines clearly stipulate that Existing guidelines clearly stipulate that treatment of at least 6 months' duration is treatment of at least 6 months' duration is necessary to reduce the risk of relapse. necessary to reduce the risk of relapse. The study complied with this by providing The study complied with this by providing active treatment with citalopram for 24 active treatment with citalopram for 24 weeks. Only patients in remission, after a weeks. Only patients in remission, after a total of 24 weeks of treatment with citalototal of 24 weeks of treatment with citalopram, were randomised to double-blind pram, were randomised to double-blind treatment with citalopram or placebo. The treatment with citalopram or placebo. The patients were closely monitored during the patients were closely monitored during the double-blind period until discontinuation double-blind period until discontinuation or completion. Patients with recurrence of or completion. Patients with recurrence of depression in the double-blind treatment depression in the double-blind treatment period were withdrawn and treated at the period were withdrawn and treated at the investigators' discretion. investigators' discretion.
In addition, an active-comparator trial In addition, an active-comparator trial can only provide information regarding recan only provide information regarding relative effect, but not whether prophylactic lative effect, but not whether prophylactic treatment is clinically warranted. The treatment is clinically warranted. The absolute value of prophylactic treatment absolute value of prophylactic treatment can only be concluded from a can only be concluded from a placeboplacebocontrolled trial. Thus, the study had a controlled trial. Thus, the study had a placebo-controlled design for the doubleplacebo-controlled design for the doubleblind period, in accordance with the blind period, in accordance with the National Health and Medical Research National Health and Medical Research Council guidelines as cited by Drs Jainer Council guidelines as cited by Drs Jainer and Soni ('If there is a genuine uncertainty and Soni ('If there is a genuine uncertainty about the net clinical benefit of a treatment, about the net clinical benefit of a treatment, a placebo controlled trial or a trial with a a placebo controlled trial or a trial with a no-treatment arm may be considered'). no-treatment arm may be considered').
The study established that long-term The study established that long-term treatment with citalopram is effective in treatment with citalopram is effective in preventing recurrence of depression in the preventing recurrence of depression in the elderly and is well tolerated. With this elderly and is well tolerated. With this knowledge, along with other currently knowledge, along with other currently available information, we certainly agree available information, we certainly agree with the authors that the appropriateness with the authors that the appropriateness of conducting similar studies in the future of conducting similar studies in the future should be considered. However, our opishould be considered. However, our opinion notwithstanding, there is no consensus nion notwithstanding, there is no consensus regarding the need for prophylactic treatregarding the need for prophylactic treatment in the elderly. Until clinical practice ment in the elderly. Until clinical practice and guidelines are changed, studies of a and guidelines are changed, studies of a similar nature will have to be undertaken similar nature will have to be undertaken to convince the scientific community of to convince the scientific community of the value of long-term treatment. the value of long-term treatment. 3) ), esti-(MMSE) score at baseline 8.9 (8.3)), estimating direct and indirect costs of dementia mating direct and indirect costs of dementia (Trabucchi (Trabucchi et al et al, 1996) . In a preliminary , 1996). In a preliminary analysis after the first year of observation, analysis after the first year of observation, using a logistic regression analysis, we using a logistic regression analysis, we found that greater annual costs for Alzheifound that greater annual costs for Alzheimer's disease are significantly associated mer's disease are significantly associated more with disability than with cognitive more with disability than with cognitive decline (Bianchetti decline (Bianchetti et al et al, 1998) . Following , 1998) . Following this line of investigation, we evaluated the this line of investigation, we evaluated the modification of costs with the progression modification of costs with the progression of the disease at the end of the 6-year longof the disease at the end of the 6-year longitudinal study with a Markov state transiitudinal study with a Markov state transition model based on the comparison of tion model based on the comparison of costs for different states of cognitive and costs for different states of cognitive and functional decline (measured using the functional decline (measured using the MMSE and the Basic Activities of Daily MMSE and the Basic Activities of Daily Living (BADL) scale) (Jonsson Living (BADL) scale) (Jö nsson et al et al, , 1999) . In our study total costs (per year) 1999). In our study total costs (per year) for dementia care varied from for dementia care varied from e e15 450 15 450 (£9972) for independent patients (BADL (£9972) for independent patients (BADL lost lost¼0), to 0), to e e21 463 (£13 853) for partially 21 463 (£13 853) for partially independent subjects (1-3 BADL lost) and independent subjects (1-3 BADL lost) and e e23 762 (£15 336) for totally dependent 23 762 (£15 336) for totally dependent patients (4-6 BADL lost). Using the patients (4-6 BADL lost). Using the MMSE, the costs varied from MMSE, the costs varied from e e18 024 18 024 (£11 633) for patients with mild Alzhei-(£11 633) for patients with mild Alzheimer's disease (MMSE mer's disease (MMSE 4 420), to 20), to e e19 665 19 665 (£12 692) for patients with moderate (£12 692) for patients with moderate decline and decline and e e25 351 25 351 (£17 077) for patients with severe cognitive (£17 077) for patients with severe cognitive decline (MMSE 8-14) (Trabucchi, 1999) . decline (Trabucchi, 1999) .
Declaration of interest Declaration of interest
Our data, obtained in a sample of subOur data, obtained in a sample of subjects with Alzheimer's disease living in a jects with Alzheimer's disease living in a different social and cultural context, different social and cultural context, strengthen those obtained by Wolstenstrengthen those obtained by Wolstenholme and colleagues, emphasising in partiholme and colleagues, emphasising in particular the need to demonstrate an effect on cular the need to demonstrate an effect on functional status in the cost-effectiveness functional status in the cost-effectiveness analysis of interventions in dementia. analysis of interventions in dementia. First, in our study 64% of the CBT First, in our study 64% of the CBT group achieved clinical improvement comgroup achieved clinical improvement compared with 47% of the controls (Kuipers pared with 47% of the controls (Kuipers et al et al, 1997). We did not present the NNT , 1997). We did not present the NNT but they are 6 at the end of treatment and but they are 6 at the end of treatment and 3 at the end of follow-up (Kuipers 3 at the end of follow-up (Kuipers et al et al, , 1998) . 1998).
Second, the two studies address differSecond, the two studies address different questions in different samples. Our ent questions in different samples. Our study tested whether CBT for psychosis study tested whether CBT for psychosis could improve outcome compared with could improve outcome compared with treatment as usual, in a sample comprising treatment as usual, in a sample comprising subjects deliberately chosen to have at subjects deliberately chosen to have at least one distressing, positive, medicationleast one distressing, positive, medicationresistant symptom of psychosis (not from resistant symptom of psychosis (not from 'lists of patients with schizophrenia receiv-'lists of patients with schizophrenia receiving treatment'; Turkington ing treatment'; Turkington et al et al, 2002 Turkington et al et al, : , 2002 ). We were aiming at a p. 523). We were aiming at a treatmenttreatmentresistant group, a rather different sample resistant group, a rather different sample from that recruited by Turkington and colfrom that recruited by Turkington and colleagues. Neither study compared 9 months leagues. Neither study compared 9 months of CBT with a briefer intervention. Nor of CBT with a briefer intervention. Nor did they test the efficacy of two different did they test the efficacy of two different kinds of CBT. kinds of CBT.
We believe that it is misleading to claim We believe that it is misleading to claim comparability of trials between 'expert' and comparability of trials between 'expert' and 'non-expert' therapists, and between results 'non-expert' therapists, and between results from 6 sessions and 20 sessions. Evidence from 6 sessions and 20 sessions. Evidence for the efficacy of CBT for psychosis is at for the efficacy of CBT for psychosis is at an early and promising stage; we think it an early and promising stage; we think it is unhelpful to make unsubstantiated comis unhelpful to make unsubstantiated comparisons across trials, and hope that these parisons across trials, and hope that these comments provide some clarification. comments provide some clarification.
Kuipers, E., Garety, P., Fowler, D., Kuipers, E., Garety, P., Fowler, D., et al et al ( Author's reply: Our study was designed speOur study was designed specifically to answer the question raised by cifically to answer the question raised by Jones Jones et al et al (1999) of whether the benefits (1999) of whether the benefits achieved by expert therapists in research achieved by expert therapists in research settings could be replicated by non-expert settings could be replicated by non-expert therapists working in community mental therapists working in community mental health teams. An end-of-therapy comparihealth teams. An end-of-therapy comparison was therefore necessary with one of son was therefore necessary with one of the methodologically robust studies quoted the methodologically robust studies quoted in the above review. Kuipers in the above review. Kuipers et al et al (1997) (1997) was chosen because a similar, good clinical was chosen because a similar, good clinical outcome analysis on overall symptoms had outcome analysis on overall symptoms had been reported at end of therapy. The approbeen reported at end of therapy. The appropriate end-of-therapy comparison is 14/28 priate end-of-therapy comparison is 14/28 (50%) for cognitive-behavioural therapy (50%) for cognitive-behavioural therapy (CBT) as measured at the level of 20% im-(CBT) as measured at the level of 20% improvement in overall symptoms in the origiprovement in overall symptoms in the original Kuipers nal Kuipers et al et al (1997) paper compared (1997) paper compared with 112/257 (44%) as measured at the with 112/257 (44%) as measured at the level of a 25% improvement in our study. level of a 25% improvement in our study. These results show a comparable effect size These results show a comparable effect size for CBT in the two studies, considering that for CBT in the two studies, considering that our study had to satisfy a more stringent our study had to satisfy a more stringent criterion for a good clinical outcome. The criterion for a good clinical outcome. The difference in the numbers needed to treat difference in the numbers needed to treat is solely due to an improved performance is solely due to an improved performance in our treatment as usual group compared in our treatment as usual group compared with standard care. with standard care.
It is certainly correct to state that the It is certainly correct to state that the two study populations were different by two study populations were different by definition. However, consideration of the definition. However, consideration of the demographics as reported in the two papers demographics as reported in the two papers shows that there was little difference in shows that there was little difference in those who actually ended up being enrolled those who actually ended up being enrolled in the two studies. The mean number of in the two studies. The mean number of admissions in Kuipers admissions in Kuipers et al et al (1997) was 5.2 (1997) was 5.2 for the CBT group and 4.3 for standard for the CBT group and 4.3 for standard care and in our study 4.71 for CBT and care and in our study 4.71 for CBT and 5.18 for treatment as usual. We ended up 5.18 for treatment as usual. We ended up enrolling a more treatment-resistant group enrolling a more treatment-resistant group because of the fact that patients with because of the fact that patients with schizophrenia whose symptoms were well schizophrenia whose symptoms were well controlled with medication often did not controlled with medication often did not see the need to enter the study when it see the need to enter the study when it was offered to them. was offered to them.
It is certainly true that the CBT delivIt is certainly true that the CBT delivered by Kuipers and colleagues was of 20 ered by Kuipers and colleagues was of 20 sessions' duration with a more sophistisessions' duration with a more sophisticated treatment manual. This makes the cated treatment manual. This makes the result of our brief CBT intervention as result of our brief CBT intervention as delivered by psychiatric nurses all the more delivered by psychiatric nurses all the more impressive. We await the analysis of our impressive. We await the analysis of our short-term follow-up results to see whether short-term follow-up results to see whether the impressive durability results reported the impressive durability results reported above can be equalled. If CBT is to make above can be equalled. If CBT is to make a real impact in terms of the management a real impact in terms of the management of schizophrenia, it will need to be delivof schizophrenia, it will need to be delivered by non-expert therapists in community ered by non-expert therapists in community mental health teams. The real issues for mental health teams. The real issues for expert cognitive therapists are to organise expert cognitive therapists are to organise training courses, provide supervision and training courses, provide supervision and to deliver more complex CBT for those to deliver more complex CBT for those patients with schizophrenia who are more patients with schizophrenia who are more psychologically difficult or who have psychologically difficult or who have comorbidity such as post-traumatic stress comorbidity such as post-traumatic stress disorder, alcohol dependence and social disorder, alcohol dependence and social phobia. There is therefore a potential role phobia. There is therefore a potential role for both expert and non-expert therapists for both expert and non-expert therapists in the management of every patient with in the management of every patient with schizophrenia. schizophrenia.
Jones, C., Cormac, I., Mota, J., Jones, C., Cormac, I., Mota, J., et al et al ( (2002) . The authors examined the efficiency of the 10-item version of ed the efficiency of the 10-item version of the Trauma Screening Questionnaire the Trauma Screening Questionnaire (TSQ) in detecting post-traumatic stress (TSQ) in detecting post-traumatic stress disorder (PTSD). In our opinion, the scale disorder (PTSD). In our opinion, the scale design has some limitations which may design has some limitations which may have a negative influence on its practical have a negative influence on its practical application. application.
First, the TSQ contains five First, the TSQ contains five rereexperiencing items and five arousal items, experiencing items and five arousal items, but not the avoidance and numbing but not the avoidance and numbing symptoms. According to DSM-IV diagsymptoms. According to DSM-IV diagnostic criteria for PTSD (American Psychinostic criteria for PTSD (American Psychiatric Association, 1994), the patient atric Association, 1994), the patient requires the presence of at least one requires the presence of at least one rereexperiencing symptom (criterion B), three experiencing symptom (criterion B), three avoidance symptoms (criterion C), and avoidance symptoms (criterion C), and two arousal symptoms (criterion D). The two arousal symptoms (criterion D). The criterion C is the least frequently met critercriterion C is the least frequently met criterion but critically significant to the diagnosis ion but critically significant to the diagnosis of PTSD (Maes of PTSD (Maes et al et al, 1998) . Some trauma , 1998). Some trauma survivors, who express most PTSD sympsurvivors, who express most PTSD symptoms, do not fulfil the avoidance criterion toms, do not fulfil the avoidance criterion and are diagnosed as having 'partial' PTSD. and are diagnosed as having 'partial' PTSD. Other briefer screening instruments, such as Other briefer screening instruments, such as the four-item SPAN (Meltzer-Brody the four-item SPAN (Meltzer-Brody et al et al, , 1999) or the seven-item scale by Breslau 1999) or the seven-item scale by Breslau et al et al (1999) , place much weight on the (1999), place much weight on the avoidance and numbing symptoms. Thereavoidance and numbing symptoms. Therefore, this specific item composition may fore, this specific item composition may influence the efficiency of the TSQ. influence the efficiency of the TSQ.
Second, the TSQ uses the frequency Second, the TSQ uses the frequency threshold allied to a 'yes/no' response threshold allied to a 'yes/no' response format. Although comparison of scores format. Although comparison of scores derived by frequency and by severity derived by frequency and by severity indicated a degree of similarity, the severity indicated a degree of similarity, the severity dimension might provide better disdimension might provide better discrimination than the frequency dimension crimination than the frequency dimension (Meltzer-Brody (Meltzer-Brody et al et al, 1999) . In our clinical , 1999). In our clinical experience, subjects can score the severity experience, subjects can score the severity variable more accurately than the frequency variable more accurately than the frequency ones (Chen ones (Chen et al et al, 2001) . The item selection , 2001). The item selection and scoring method have greater influence and scoring method have greater influence on the efficacy of the rating scale. on the efficacy of the rating scale. , 2002 ) is flawed because it omits avoidance and numbing because it omits avoidance and numbing symptoms and asks about symptom fresymptoms and asks about symptom frequency using a simple 'yes/no' response quency using a simple 'yes/no' response format. It is puzzling then that the perforformat. It is puzzling then that the performance of the TSQ is superior to that of mance of the TSQ is superior to that of all comparable screening measures, inall comparable screening measures, including ones that follow Lu and Shen's cluding ones that follow Lu and Shen's recommendations. Their views are clearly recommendations. Their views are clearly contradicted by the data from the two contradicted by the data from the two studies we reported. Our reasons for studies we reported. Our reasons for designing the TSQ in the way we did designing the TSQ in the way we did were based on empirical and practical were based on empirical and practical rather than theoretical considerations. In rather than theoretical considerations. In our original article we discussed some our original article we discussed some general principles for designing successful general principles for designing successful screening instruments, whereas Lu and screening instruments, whereas Lu and Shen's comments seem more relevant to Shen's comments seem more relevant to a diagnostic instrument. The two types a diagnostic instrument. The two types of measure tend to be administered by of measure tend to be administered by different professionals, under different different professionals, under different circumstances, and with different aims in circumstances, and with different aims in mind. It seems to us that, as a screening mind. It seems to us that, as a screening instrument, what the TSQ gains in simpliinstrument, what the TSQ gains in simplicity and clarity more than compensates city and clarity more than compensates for the absence of symptoms that may for the absence of symptoms that may be difficult to understand and judgements be difficult to understand and judgements that may be difficult to make. that may be difficult to make. (2002) address the interesting area of explanatory models for teresting area of explanatory models for mental distress. They do not, however, jusmental distress. They do not, however, justify why we should elicit patients' explanatify why we should elicit patients' explanatory models. The notion that members of a tory models. The notion that members of a specific cultural group hold similar ideas specific cultural group hold similar ideas about illness and that culture can be disabout illness and that culture can be distilled into a set of specific 'beliefs' is contilled into a set of specific 'beliefs' is considered outdated and oversimplified by sidered outdated and oversimplified by medical anthropologists. Kleinman (1980) medical anthropologists. Kleinman (1980) points out that explanatory models are points out that explanatory models are idiosyncratic and are justifications for acidiosyncratic and are justifications for actions rather than causes. Bhui & Bhugra tions rather than causes. Bhui & Bhugra themselves cite Williams & Healy (2001), themselves cite Williams & Healy (2001), who point out that it is difficult to distil a who point out that it is difficult to distil a single set of causal explanations that might single set of causal explanations that might relate to behaviour, diagnosis or adherence relate to behaviour, diagnosis or adherence to medication treatment. to medication treatment.
The assertion by Bhui & Bhugra that The assertion by Bhui & Bhugra that shared understanding of illness between shared understanding of illness between patient and healer distinguishes traditional patient and healer distinguishes traditional healing systems from Western biomedicine healing systems from Western biomedicine is simply not borne out by the anthropolois simply not borne out by the anthropological literature. In many systems of tragical literature. In many systems of traditional healing, patients have little ditional healing, patients have little understanding of how the treatment understanding of how the treatment 'works' and it is the healer who holds 'works' and it is the healer who holds highly esoteric knowledge. There is little highly esoteric knowledge. There is little empirical evidence that eliciting explanaempirical evidence that eliciting explanatory models improves satisfaction. The tory models improves satisfaction. The one study cited (Callan & Littlewood, one study cited (Callan & Littlewood, 1998) in fact found that 79% of patients 1998) in fact found that 79% of patients with divergent explanatory models (a comwith divergent explanatory models (a comparison of the explanatory models of docparison of the explanatory models of doctors and patients) were satisfied with tors and patients) were satisfied with psychiatric services. psychiatric services.
Of course, patients do have cultural unOf course, patients do have cultural understanding of their illness but this may not derstanding of their illness but this may not be very sophisticated and may not directly be very sophisticated and may not directly relate to decisions about treatments. There relate to decisions about treatments. There is a large amount of data from medical is a large amount of data from medical anthropological research which suggests anthropological research which suggests that treatment choice is determined primarthat treatment choice is determined primarily by social and political factors rather ily by social and political factors rather than by underlying explanatory models than by underlying explanatory models (Pelto & Pelto, 1997) . Even a study using (Pelto & Pelto, 1997) . Even a study using the Explanatory Model Interview Catalothe Explanatory Model Interview Catalogue (Weiss gue (Weiss et al et al, 1992) among leprosy , 1992) among leprosy patients suggests that those who held patients suggests that those who held theories of humoral imbalance rather than theories of humoral imbalance rather than biomedical theories of infection, sanitation biomedical theories of infection, sanitation and hygiene had the best biomedical clinic and hygiene had the best biomedical clinic attendance records for leprosy treatment. attendance records for leprosy treatment. In terms of treatment outcomes patients In terms of treatment outcomes patients may not be interested in how a treatment may not be interested in how a treatment works (Last, 1981) as long as it does work. works (Last, 1981) as long as it does work. The weight of empirical evidence suggests The weight of empirical evidence suggests that people are keen to utilise biomedical that people are keen to utilise biomedical treatments regardless of their cultural betreatments regardless of their cultural beliefs without giving up traditional explanaliefs without giving up traditional explanations of illness. In fact, as my own data tions of illness. In fact, as my own data (Dein, 2001) 's (2002) article on pathways to care for children at article on pathways to care for children at risk of attention-deficit hyperactivity disorrisk of attention-deficit hyperactivity disorder (ADHD). By using Goldberg & Huxder (ADHD). By using Goldberg & Huxley's (1980) pathway to care model I felt ley's (1980) pathway to care model I felt that the study oversimplified the complexthat the study oversimplified the complexity of professional input to this group of ity of professional input to this group of children, a point raised by the authors in children, a point raised by the authors in their discussion. I think it is important, their discussion. I think it is important, when considering improvements to services when considering improvements to services for children with ADHD, that the role of for children with ADHD, that the role of education is highlighted. education is highlighted.
Teachers, as a profession, are well Teachers, as a profession, are well placed to observe children and are familiar placed to observe children and are familiar with age-appropriate behaviour. Indeed, with age-appropriate behaviour. Indeed, Goodman Goodman et al et al (2000) found that teachers (2000) found that teachers were more sensitive at identifying children were more sensitive at identifying children with hyperactivity than were their parents. with hyperactivity than were their parents. Although teachers' involvement in the asAlthough teachers' involvement in the assessment and monitoring of children with sessment and monitoring of children with ADHD is well established (Dulcan ADHD is well established (Dulcan et al et al, , 1997) , their role in identification is less 1997), their role in identification is less clear. This is highlighted by the fact that clear. This is highlighted by the fact that only some child and adolescent mental only some child and adolescent mental health services (CAMHS) accept referrals health services (CAMHS) accept referrals directly from schools. By involving teachers directly from schools. By involving teachers in the identification of children with in the identification of children with ADHD, access to children would improve ADHD, access to children would improve from 74% seen in primary care to nearly from 74% seen in primary care to nearly 100%. This would significantly improve 100%. This would significantly improve the sensitivity of any screening measure. the sensitivity of any screening measure.
It is essential that CAMHS do not It is essential that CAMHS do not develop services for children in isolation, develop services for children in isolation, but instead utilise the skills of other but instead utilise the skills of other professionals to improve care. If children professionals to improve care. If children with ADHD are to have their needs met, with ADHD are to have their needs met, it is essential that we start to think outside it is essential that we start to think outside of the medical model. of the medical model. (Sayal et al et al, , 2002 ) also highlights the potential role of 2002) also highlights the potential role of both parents and teachers in making referboth parents and teachers in making referrals to child and adolescent mental health rals to child and adolescent mental health services (CAMHS). The paper is developing services (CAMHS). The paper is developing new methodology and we deliberately new methodology and we deliberately posed it on a simplified system, selecting posed it on a simplified system, selecting an area where most referrals come from an area where most referrals come from general practitioners (GPs). GPs are also general practitioners (GPs). GPs are also the main referrers to CAMHS nationally the main referrers to CAMHS nationally and their role in primary care trusts will and their role in primary care trusts will be of great importance in shaping specialist be of great importance in shaping specialist services. Nevertheless, this is only one comservices. Nevertheless, this is only one component of tier 1 services and 48% of ponent of tier 1 services and 48% of CAMHS referrals come from other sources CAMHS referrals come from other sources (Audit Commission, 1999) . We plan to (Audit Commission, 1999) . We plan to widen our programme to examine the role widen our programme to examine the role of other sources of referral. of other sources of referral.
Restricting referrals to particular agenRestricting referrals to particular agencies imposes barriers to access, and the recies imposes barriers to access, and the resulting delay in referrals might exacerbate sulting delay in referrals might exacerbate severity or chronicity of problems. Kurtz severity or chronicity of problems. Kurtz et al et al (1996) described a service that only (1996) described a service that only accepted GP referrals. It failed to reduce accepted GP referrals. It failed to reduce the number of referrals and generated rethe number of referrals and generated resentment from other agencies. Comparisentment from other agencies. Comparisons of CAMHS with different referral sons of CAMHS with different referral systems will improve knowledge in quantisystems will improve knowledge in quantifying the barriers to access to services. This fying the barriers to access to services. This could contribute to assisting the successful could contribute to assisting the successful implementation of the National Service implementation of the National Service Framework for Children. Framework for Children.
The role of teachers in the pathway to The role of teachers in the pathway to care merits particular comment. Relationcare merits particular comment. Relationship difficulties with teachers are a predicship difficulties with teachers are a predictor of referral of hyperactive children to tor of referral of hyperactive children to CAMHS (Woodward CAMHS (Woodward et al et al, 1997) . Our , 1997) . Our study has demonstrated that selective tarstudy has demonstrated that selective targeting can lead to particularly high rates geting can lead to particularly high rates (98%) of teacher participation in research. (98%) of teacher participation in research. This is likely to reflect their concern about This is likely to reflect their concern about behavioural and emotional difficulties in behavioural and emotional difficulties in children. Teachers are a rich potential children. Teachers are a rich potential source of child mental health information source of child mental health information for parents. However, in considering referfor parents. However, in considering referrals from schools, it is imperative that rals from schools, it is imperative that teachers fully discuss their concerns with teachers fully discuss their concerns with parents. Parents need to agree to any referparents. Parents need to agree to any referral. For hyperactivity, in particular, it needs ral. For hyperactivity, in particular, it needs to be ascertained that the problems are perto be ascertained that the problems are pervasive. Unless this happens, there is a risk vasive. Unless this happens, there is a risk that learning difficulties are wrongly identithat learning difficulties are wrongly identified as hyperactivity. This also highlights fied as hyperactivity. This also highlights the importance of adequately resourced the importance of adequately resourced educational psychology services to support educational psychology services to support schools, and health service input in the schools, and health service input in the training of teachers. training of teachers. Consciousness still a mystery Consciousness still a mystery Baroness Greenfield's (2002) editorial is Baroness editorial is shaped by the metaphors of empiricism. shaped by the metaphors of empiricism. The brain is a network. The mind is distinct The brain is a network. The mind is distinct patterns of neural connectivity. Currently, patterns of neural connectivity. Currently, the evidence for such a scenario is limited. the evidence for such a scenario is limited. Brain connections may, as she says, 'actuBrain connections may, as she says, 'actually reflect experience', but no pattern of ally reflect experience', but no pattern of connectivity has ever been related to any connectivity has ever been related to any particular mental state. The alternative particular mental state. The alternative hypothesis of functional specialisation hypothesis of functional specialisation merits more than the scant consideration merits more than the scant consideration granted in the editorial, given the recent granted in the editorial, given the recent interest in the notion of modularity (Fodor, interest in the notion of modularity Pinker, 1999) . Perversely, Greenfield 1983; Pinker, 1999) . Perversely, Greenfield chooses to support her 'network' hypochooses to support her 'network' hypothesis by reference to a study showing thesis by reference to a study showing regionally localised brain changes in taxi regionally localised brain changes in taxi drivers (Maguire drivers (Maguire et al et al, 2000) . , 2000). Consciousness is introduced as a dimenConsciousness is introduced as a dimensional variable quantifying the current sional variable quantifying the current extent of this connectivity. Seemingly, the extent of this connectivity. Seemingly, the more connected our brains are the more more connected our brains are the more conscious we are. But is this anything more conscious we are. But is this anything more than metaphorical fooling around? She than metaphorical fooling around? She presents no evidence for what a conscious presents no evidence for what a conscious brain state might look like. Where conbrain state might look like. Where consciousness occurs is surely rather an unsciousness occurs is surely rather an unimportant issue. The hard question, which important issue. The hard question, which Greenfield ignores, is 'How can pain Greenfield ignores, is 'How can pain (which hurts so) possibly be the same thing (which hurts so) possibly be the same thing as insensate molecules rushing around in as insensate molecules rushing around in nerve fibres?' . On this nerve fibres?' . On this our ignorance remains as complete as it our ignorance remains as complete as it ever was. ever was.
